Aklief

Active Ingredient(s): Trifarotene
FDA Approved: * October 4, 2019
Pharm Company: * GALDERMA RESEARCH AND DEV INC
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Recent Aklief Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Trifarotene
  • Cream: 0.005%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Aklief: (1 result)

Sorted by National Drug Code
  • 0299-5935 Aklief 50 ug/g Topical Cream by Galderma Laboratories, L.p.

Other drugs which contain Trifarotene or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA